The US Oncology Network’s Post

READ: This poster, based on research by McKesson Director of Payer Analytics John Albaugh, delivered at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, discusses how biosimilars can help bring down healthcare costs and make treatment more accessible to more patients. Read the full article below. https://lnkd.in/eFbhn2vP #HealthInnovation #HealthcareCosts #ASCO2024

MaryBeth Rogers

Results driven executive with 20+years of experience in driving revenue growth in Med Tech and Specialty Biologics Sales with emphasis on Advanced Wound Care, Tissue Regeneration, and New Technologies.

4mo

Well Done!

To view or add a comment, sign in

Explore topics